IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.


Structure & Governance

Leadership Teams

Central operation, strategy and development of APGI research and services are governed by particular teams.

Read More…


The APGI is based at the Garvan Institute of Medical Research in Sydney and the Institute of Molecular Bioscience in Brisbane. Our collaborators have included pancreatic cancer healthcare professionals and experts in major hospitals and research facilities across Australia. We also have international links with major pancreatic healthcare research centres in the USA, Canada and Italy. This project would not have been possible without the dedication and support of each and everyone of you. From the APGI team, a very big thank you to all!

Read More…